Skip to content

Drug interactions

Acalabrutinib + Dabigatran etexilate

Severity: Moderate

Acalabrutinib and Dabigatran etexilate: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Acalabrutinib impairs platelet function and is associated with bleeding events, so combining it with dabigatran raises the risk of hemorrhage.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to see why Acalabrutinib and Dabigatran etexilate interact, what to do about it, and the sources.

  • Mechanism of action
  • Clinical management
  • Evidence level

Free 14-day trial. No card needed.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions